Company Info
| Industry | Miscellaneous Commercial Services |
|---|---|
| Sector | Commercial Services |
| Employees | 20 |
| CEO | Mr. Clifford Press |
| Address | 767 3rd Avenue Suite 602, New York, NY 10017 |
|---|---|
| Phone | 1.332.236.8500 |
| Website | www.acaciaresearch.com |
Acacia Research Corp. engages in the acquisition, development, and patents technologies through its subsidiaries. Its operating subsidiaries assist patent owners with the prosecution and development of their patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing revenue from users of their patented technologies and, if necessary, with the enforcement against unauthorized users of their patented technologies. The company was founded by Robert Bruce Stewart on January 25, 1993 and is headquartered in New York, NY.
Competitors
| Company Name | 3 Month %Change |
1 Year %Change |
|---|---|---|
| Acacia Research Corp. | -8.14% | 37.04% |
| TrueBlue, Inc. | 0.00% | 28.67% |
| Viad Corp. | 7.91% | 47.84% |
| Century Therapeutics, Inc. | -26.24% | n/a |
| Winmark Corp. | 31.38% | 47.61% |
Statement Summary
as of 4:00 ET PM 11/24/2021| Total Assets (MRQ) | 749.8 M |
|---|---|
| Total Liabilities (MRQ) | 500.3 M |
| Shareholders’ Equity (MRQ) | 249.5 M |
| Total Revenue (Annual) | 1.6 M |
| Net Income (Annual) | 74.2 M |
Earnings And Estimates
as of 1:00 ET PM 11/26/2021
| Current Qtr EPS Estimate | -0.04 |
|---|---|
| Current FY EPS Estimate | -1.57 |
| Long Term EPS Growth Estimate | 20.00 |
| Next Expected Earnings Date | // |
ACTG vs S&P 500
as of 11/26/2021| Relative To S&P 500 |
ACTG | |
|---|---|---|
| 4 Weeks | n/a | n/a |
| 12 Weeks | n/a | n/a |
| YTD | n/a | n/a |
Earnings Surprises
as of 1:00 ET PM 11/26/2021| Fiscal Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 09/2021 | -0.06 | 0.89 | -1,583.33% |
| 06/2021 | 0.05 | 0.36 | +624.93% |
| 03/2021 | 0.05 | -5.62 | -11,345.97% |
| 12/2020 | -0.01 | -0.46 | +4,531.07% |
| 09/2020 | -0.02 | -0.13 | +535.21% |
| 06/2020 | -0.02 | -0.10 | +416.39% |
| 09/2018 | -0.08 | -0.56 | +600.00% |
| 06/2018 | -0.08 | 0.13 | -262.50% |
Financial Strength
as of 1:00 ET PM 11/26/2021| Pre-Tax Margin | 5.00 |
|---|---|
| Net Margin | 2.00 |
| Operating Margin | -804.17 |
| Return On Equity | 9.83 |
| Return On Assets | 3.66 |
| Inventory Turnover (TTM) | 0.00 |
| Sales Growth (MRQ) | -24.94 |
Ratios
as of 1:00 PM ET 11/26/2021| Price/Earnings (TTM) | n/a |
|---|---|
| Price/Book (MRQ) | 1.15 |
| Price/Cash Flow (TTM) | 0.00 |
| Book Value (MRQ) | 4.52 |
| Quick Ratio (MRQ) | 3.27 |
| Current Ratio (MRQ) | 3.27 |
| Total Debt/Equity (MRQ) | 0.77 |
Short Interest
as of 9:56 AM ET 11/29/2021| % Short - 0.00% | |
| % Remaining Float - 100.00% |
| Current | Last Month | |
|---|---|---|
| Short Interest Date | n/a | n/a |
| Short Interest Shares | 0 | 0 |
| Short Interest Ratio | 0.0 | 0.0 |
M Y M Y
Total Assets 0,0.00 0,0.00
Total Liabilities 0,0.00 0,0.00
Total Equity 0,0.00 0,0.00
M Y M Y
Total Revenue 0,0.00 0,0.00
EBT Exc.
Unusual Items
0,0.00
0,0.00
Net Income 0,0.00 0,0.00
M Y M Y
Cash from
Operations
0,0.00
0,0.00
Cash from
Activities
0,0.00
0,0.00
Cash from
Fin. Activities
0,0.00
0,0.00
TOTAL ASSETS |
TOTAL LIABILITIES |
TOTAL EQUITY |
|---|---|---|
Balance Sheet
| M Y | ||||
|---|---|---|---|---|
| ASSETS | ||||
| Cash And Equivalents | 0,0.00 | |||
| Receivables | 0,0.00 | |||
| Inventories | 0,0.00 | |||
| Other Current Assets | 0,0.00 | |||
| Total Current Assets | 0,0.00 | |||
| Property, Plant & Equipment, Gross | 0,0.00 | |||
| Accumulated Depreciation & Depletion | 0,0.00 | |||
| Property, Plant & Equipment, Net | 0,0.00 | |||
| Intangibles | 0,0.00 | |||
| Other Non-Current Assets | 0,0.00 | |||
| Total Non-Current Assets | 0,0.00 | |||
| TOTAL ASSETS | 0,0.00 | |||
| Liabilities & Shareholder Equity | ||||
| Accounts Payable | 0,0.00 | |||
| Short Term Debt | 0,0.00 | |||
| Total Current Liabilities | 0,0.00 | |||
| Long Term Debt | 0,0.00 | |||
| Deferred Income Taxes | 0,0.00 | |||
| Other Non-Current Liabilities | 0,0.00 | |||
| Minority Interest | 0,0.00 | |||
| Total Non-Current Liabilities | 0,0.00 | |||
| Preferred Stock Equity | 0,0.00 | |||
| Common Stock Equity | 0,0.00 | |||
| Common Par | 0,0.00 | |||
| Additional Paid In Capital | 0,0.00 | |||
| Cumulative Translation Adjustment | 0,0.00 | |||
| Retained Earnings | 0,0.00 | |||
| Treasury Stock | 0,0.00 | |||
| Other Equity Adjustments | 0,0.00 | |||
| Total Capitalization | 0,0.00 | |||
| TOTAL EQUITY | 0,0.00 | |||
| TOTAL LIABILITIES & STOCK EQUITY | 0,0.00 | |||
| Total Common Shares Outstanding | 0,0.00 | |||
| Preferred Shares | 0,0.00 | |||
| Treasury Shares | 0,0.00 | |||
| Basic Weighted Shares Outstanding | 0,0.00 | |||
| Diluted Weighted Shares Outstanding | 0,0.00 | |||
| Number Of Employees | 0,0.00 | |||
| Number Of Part-Time Employees | 0,0.00 | |||
TOTAL REVENUES |
EBT Excluding Unusual Items |
NET INCOME |
|---|---|---|
Income Statement
| M Y | |
|---|---|
| Sales | 0,0.00 |
| Cost Of Sales | 0,0.00 |
| Gross Operating Profit | 0,0.00 |
| Selling, General, And Administrative Expenses | 0,0.00 |
| Research & Development | 0,0.00 |
| Operating Income Before D & A (EBITDA) | 0,0.00 |
| Depreciation & Amortization | 0,0.00 |
| Interest Income | 0,0.00 |
| Other Income - Net | 0,0.00 |
| Special Income / Charges | 0,0.00 |
| Total Income Before Interest Expenses (EBIT) | 0,0.00 |
| Interest Expense | 0,0.00 |
| Pre-Tax Income | 0,0.00 |
| Income Taxes | 0,0.00 |
| Minority Interest | 0,0.00 |
| Net Income From Continuing Operations | 0,0.00 |
| Net Income From Discontinued Operations | 0,0.00 |
| Net Income From Total Operations | 0,0.00 |
| Extraordinary Income/Losses | 0,0.00 |
| Income From Cum. Effect Of Acct. Change | 0,0.00 |
| Income From Tax Loss Carryforward | 0,0.00 |
| Other Gains / Losses | 0,0.00 |
| Total Net Income | 0,0.00 |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
0,0.00 |
| Preferred Dividends | 0,0.00 |
| Net Income Available To Common | 0,0.00 |
| Basic EPS From Continuing Ops. | 0,0.00 |
| Basic EPS From Discontinued Ops. | 0,0.00 |
| Basic EPS From Total Operations | 0,0.00 |
| Basic EPS From Extraordinary Inc. | 0,0.00 |
| Basic EPS From Cum Effect Of Accounting Change | 0,0.00 |
| Basic EPS From Tax Loss Carryf'd. | 0,0.00 |
| Basic EPS From Other Gains (Losses) | 0,0.00 |
| Basic EPS, Total | 0,0.00 |
| Basic Normalized Net Income/Share | 0,0.00 |
| EPS From Continuing Ops. | 0,0.00 |
| EPS From Discontinued Ops | 0,0.00 |
| EPS From Total Ops. | 0,0.00 |
| EPS From Extraord. Inc. | 0,0.00 |
| EPS From Cum Effect of Accounting Change | 0,0.00 |
| EPS From Tax Loss Carfd. | 0,0.00 |
| EPS From Other Gains (L) | 0,0.00 |
| EPS, Total | 0,0.00 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
0,0.00 |
| Dividends Paid Per Share | 0,0.00 |
CASH FROM OPERATIONS |
CASH FROM INVESTING ACTIVITIES |
CASH FROM FINANCING ACTIVITIES |
|---|---|---|
Cash Flow Statement
| M Y | ||||
|---|---|---|---|---|
| Cash Flow From Operating Activities | ||||
| Net Income (Loss) | 0,0.00 | |||
| Operating Gains/Losses | 0,0.00 | |||
| Gross Operating Profit | 0,0.00 | |||
| (Increase) Decrease In Receivables | 0,0.00 | |||
| (Increase) Decrease In Inventories | 0,0.00 | |||
| (Increase) Decrease In Other Current Assets | 0,0.00 | |||
| (Decrease) Increase In Other Current Liabilities | 0,0.00 | |||
| (Increase) Decrease In Other Working Capital | 0,0.00 | |||
| Other Non-Cash Items | 0,0.00 | |||
| Net Cash From Continuing Operations | 0,0.00 | |||
| Net Cash From Discontinued Operations | 0,0.00 | |||
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 0,0.00 | |||
| Sale Of Property, Plant & Equipment | 0,0.00 | |||
| Cash Used For Investing Activities | ||||
| Sale Of Short-Term Investments | 0,0.00 | |||
| Purchases Of Property, Plant & Equipment | 0,0.00 | |||
| Acquisitions | 0,0.00 | |||
| Purchases Of Short-Term Investments | 0,0.00 | |||
| Other Cash From Investing Activities | 0,0.00 | |||
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 0,0.00 | |||
| Issuance Of Debt | 0,0.00 | |||
| Cash Used For Financing Activities | ||||
| Issuance Of Capital Stock | 0,0.00 | |||
| Repayment Of Long-Term Debt | 0,0.00 | |||
| Repurchase Of Capital Stock | 0,0.00 | |||
| Payment Of Cash Dividends | 0,0.00 | |||
| Other Financing Charges, Net | 0,0.00 | |||
| Net Cash From Financing Activities | 0,0.00 | |||
| Effect Of Exchange Rate Changes | 0,0.00 | |||
| Net Change In Cash & Cash Equivalents | 0,0.00 | |||
Earnings Estimates
as of 4:00 ET PM 11/24/2021| Current Qtr (12/2021) |
Next Qtr (03/2022) |
|
|---|---|---|
| Consensus Estimate | $-0.04 | $0.06 |
| # of Estimates | 1 | 1 |
| High Estimate | $-0.04 | $0.06 |
| Low Estimate | $-0.04 | $0.06 |
| Year Ago EPS | $1.35 | $-2.81 |
| Year Over Year Growth Estimate | -102.96% | -102.13% |
| Current Yr (12/2021) |
Next Yr (12/2022) |
|
|---|---|---|
| Consensus Estimate | $-1.57 | $0.23 |
| # of Estimates | 1 | 1 |
| High Estimate | $-1.57 | $0.23 |
| Low Estimate | $-1.57 | $0.23 |
| Year Ago EPS | $-1.07 | $-1.57 |
| Year Over Year Growth Estimate | 46.30% | -114.65% |
| Current Qtr (12/2021) |
Next Qtr (03/2022) |
Current Year (12/2021) |
Next Year (12/2022) |
|
|---|---|---|---|---|
| Consensus Estimate | $-0.04 | $0.06 | $-1.57 | $0.23 |
| # of Estimates | 1 | 1 | 1 | 1 |
| High Estimate | $-0.04 | $0.06 | $-1.57 | $0.23 |
| Low Estimate | $-0.04 | $0.06 | $-1.57 | $0.23 |
| Year Ago EPS | $1.35 | $-2.81 | $-1.07 | $-1.57 |
| Year Over Year Growth Estimate | -102.96% | -102.13% | 46.30% | -114.65% |
Insider Information Summary
as of 10/31/2021| % Insiders - 3.98% | |
| % Remaining Total Shares - 96.02% |
| Current | 1 Month | |
|---|---|---|
| Net Insider Transaction | 229.42 K | 229.42 K |
| Shares Bought | 229.42 K | 229.42 K |
| Shares Sold | 0.00 | 0.00 |
Insider Activity
| Transaction Date | Insider/Title | Transaction Type | Market Value | Shares | Average Price | Current Holdings | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Learn to Trade Like a Pro
Master The Market with the Help of Our Financial Experts
LATEST NEWS
Latest News
How Apple and Nokia could both score victories in their battle over patents
Dec 23, 2016 10:48 AM EST
Apple steps up its war on 'patent trolls'
Dec 21, 2016 11:15 AM EST
Insider Trading Alert - ACTG, RNR And ICPT Traded By Insiders
May 5, 2016 1:30 PM EDT
Insider Trading Alert - PLAB, ACTG And CP Traded By Insiders
Apr 28, 2016 11:15 AM EDT
5 stocks set to soar on bullish earnings
Apr 19, 2016 1:58 PM EDT
Acacia Research (ACTG) Weak On High Volume
Mar 22, 2016 10:01 AM EDT
Acacia Research (ACTG): Today's Weak On High Volume Stock
Mar 15, 2016 10:00 AM EDT
Here’s Why Acacia Research (ACTG) Stock is Jumping Today
Mar 14, 2016 2:47 PM EDT
Acacia Research (ACTG) Is Today's Strong On High Volume Stock
Mar 14, 2016 10:01 AM EDT
7 stocks under $10 to trade for big breakouts
Feb 4, 2016 2:38 PM EST
These 8 stocks under $10 are making big moves higher.
Jan 22, 2016 7:14 AM EST
What To Sell: 3 Sell-Rated Dividend Stocks IEP, VTTI, ACTG
Jan 15, 2016 10:30 AM EST
3 Sell-Rated Dividend Stocks: KNOP, CHMI, ACTG
Jan 7, 2016 10:30 AM EST
Acacia Research (ACTG) Is Today's Strong On High Volume Stock
Dec 31, 2015 10:01 AM EST
Weak On High Volume: Acacia Research (ACTG)
Dec 22, 2015 10:06 AM EST
Insider Trading Alert - BDX, CLSN And ACTG Traded By Insiders
Dec 2, 2015 12:17 PM EST
Insider Trading Alert - ADM, EBTC And ACTG Traded By Insiders
Dec 1, 2015 12:45 PM EST
What To Sell: 3 Sell-Rated Dividend Stocks IEP, CIO, ACTG
Nov 27, 2015 10:30 AM EST
Insider Trading Alert - ACTG, BSET And MCHP Traded By Insiders
Nov 25, 2015 1:30 PM EST
What To Sell: 3 Sell-Rated Dividend Stocks ACTG, NAO, CCUR
Nov 17, 2015 10:30 AM EST
Ex-Dividends To Watch: 3 Stocks Going Ex-Dividend Tomorrow: ACTG, WAFD, CTAS
Nov 3, 2015 10:00 AM EST
What To Sell: 3 Sell-Rated Dividend Stocks KNOP, ANH, ACTG
Oct 29, 2015 12:30 PM EDT
Insider Trading Alert - UG, ACTG And GK Traded By Insiders
Jun 9, 2015 12:30 PM EDT
Insider Trading Alert - CSV, ACTG And GCAP Traded By Insiders
Jun 4, 2015 1:45 PM EDT
Recent Articles from TheStreet
Walmart CFO Brett Biggs Leaving After 22 Years
Walmart says Biggs stay on as CFO until a successor is named and will remain as an associate until he leaves in January 2023.
Bristol Myers Stock Falls Despite Positive News on Psoriasis Drug
Bristol Myers shares fall after the FDA accepts its psoriasis-treating deucravacitinib drug application, and European regulators also validate its application.
Best Buy, Big-Box Store Inventory Strong, Roku Demand High: Wedbush
Wedbush finds no shortage of in-store inventory for consumer electronics. And it says Roku products are in strong demand.
Twitter Stock Leaps Amid Report CEO Jack Dorsey Will Step Down
Twitter co-founder Jack Dorsey is set to step-down as CEO of the microblogging website, CNBC reported Monday.
Wells Fargo Bullish on Quality Stocks, Despite Omicron
'We do not recommend de-risking into weakness,' Chris Harvey, head of equity strategy for Wells, writes in a commentary.
Amazon Invests in Bypassing Retail Supply Chain Issues
Amazon has built more than 450 new facilities nationwide in recent months in order to beat supply chain issues.
Cryptocurrency Price Check: Bitcoin Bounces Back After Omicron Scare
Bitcoin 'is leading the market back from the depths of despair,' a cryptocurrency analyst says.
Premarket Movers Monday: Moderna, Zoom Video
Stock futures rose Monday amid travel curbs tied to the omicron Covid variant.
Pfizer Stock Jumps On Plan To Boost Covid Pill Production In Fight Against Omicron Variant
Pfizer CEO Albert Bourla confirmed the drugmaker's plans to boost production of its Paxlovid antivrical treatment in the first against the spread of the new Omicron variant.
Tech Stocks Lead As Omicron Fears Linger; Pfizer, Moderna, Twitter Move Higher - Stock Market Today
Wall Street looks to rebound from the worst Black Friday session on record Monday as investors continue to track developments in the spread of the newly-discovered Omicron variant.